Browse drugs

… and cobalt—has long been recognized as a biochemical action of metformin.1 The chemical properties of complexes formed between metformin…

…ted the true neuroprotective effects of GLP-1 RAs compared with metformin. This underscores the potential superiority of GLP-1 RAs and hi…

…tality did not differ (HR 1.039, CI 0.594 to 1.816).Conclusions Metformin could have repurposed benefits in epilepsy. This warrants furth…

…y score matching was performed to compare patients treated with lobeglitazone plus metformin with those receiving metformin monotherapy, sulf…

…rometry (Q Exactive Plus instrumentation) were used to quantify metformin concentrations. Values below 100 ng/ml were deemed subtherapeut…

…bo or pre–post studies) reporting significant results favouring metformin in 83.3% (30/36). A knowledge gap also exists for metformin use…

… and without a diagnosis of POAG prior to diabetes diagnosis or metformin use. Bivariate logistic regression, multivariable logistic regr…

…s (338.7 vs 412.8 pmol/L, p<0.001) were significantly lower, in metformin users. Multiple regression analysis including variables that po…

…dings remained after adjusting for important confounders. Given metformin’s anti-ageing therapeutic effects, the reduction in risk is pla…

…ments to promote brain repair are needed. The antidiabetic drug metformin has recently been recognised as a neurorestorative agent, but, …

…used by proliferation of residual lens epithelial cells (LECs). Metformin, a common antidiabetic drug with antifibrotic properties, may a…

…he results of the ongoing SEPRA trial, we found that injectable semaglutide was superior to SoC with 30% more patients achieving A1C <7% at…